Thought Leadership

Drug Enforcement Administration (DEA) Mandates Registered Physicians and Healthcare Providers Complete 8-hour CME Training on the Treatment and Management of Patients with Opioid or Other Substance Use Disorders
Drug Enforcement Administration (DEA) Mandates Registered Physicians and Healthcare Providers Complete 8-hour CME Training on the Treatment and Management of Patients with Opioid or Other Substance Use Disorders
Thought Leadership
By PMN Support
 - 
July 27, 2023
Drug Enforcement Administration (DEA) Mandates Registered Physicians and Healthcare Providers Complete 8-hour CME Training on the Treatment and Management of Patients with Opioid or Other Substance Use Disorders
Read More
Landmark Study Raises ‘Serious Questions about the Use of Opioids When Treating Acute Low Back and Neck Pain’
Landmark Study Raises ‘Serious Questions about the Use of Opioids When Treating Acute Low Back and Neck Pain’
Thought Leadership
By PMN Support
 - 
July 5, 2023
Landmark Study Raises ‘Serious Questions about the Use of Opioids When Treating Acute Low Back and Neck Pain’
Read More
FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose
FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose
Thought Leadership
By PMN Support
 - 
June 8, 2023
FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose
Read More
FDA Announces New Safety Label Changes for Opioid Pain Medicines
FDA Announces New Safety Label Changes for Opioid Pain Medicines
Thought Leadership
By PMN Support
 - 
April 20, 2023
FDA Announces New Safety Label Changes for Opioid Pain Medicines
Read More
1 2